一次性设备如何重新定义内窥诊疗

医疗机构正在重新思考诊断操作的执行方式，尤其是感染控制至关重要的场景。一次性设备的采用正在加速，医院和门诊都在寻求降低交叉污染风险的同时保持诊疗效率。在这个大背景下，一次性内窥镜市场正在成为现代诊断工作流程中的重要组成部分，特别是在高风险、高负荷的医疗环境中。

Healthcare providers are increasingly rethinking how diagnostic procedures are conducted, especially in environments where infection control is critical. The shift toward single-use devices is gaining traction as hospitals and outpatient facilities look to minimize cross-contamination risks while maintaining efficiency. The disposable endoscopes market is becoming an essential part of modern diagnostic workflows.

市场以15.1%的五年CAGR增长至2025年的$22.38亿，到2030年将达$44.43亿（CAGR 14.7%），长期增长趋势非常明确。

The disposable endoscopes market reached $2,238.1 million in 2025, growing at a CAGR of 15.1% since 2020. It is projected to reach $4,443.3 million by 2030 at a CAGR of 14.7%.

产品创新与临床需求分化

胃镜在常规诊断中的广泛使用使其占据最大市场份额，而支气管镜正在快速增长——呼吸系统疾病和重症监护领域的强劲需求是背后的推动力。这种品类分化反映了临床环境对更专业化、更具适应性的诊断工具的需求。

Gastroscopes currently lead due to their widespread use in routine diagnostics. Bronchoscopes are seeing faster growth, driven by rising demand in respiratory care and critical care environments.

成人患者仍然是最大的应用群体，手术量高是主要原因。小儿科的需求也在增长，专科医疗的扩展是主要推手。医院作为主要使用者依靠基础设施和患者量保持领先，门诊手术中心（ASC）随门诊护理的普及正在快速扩张，诊断中心在去中心化检测中扮演着越来越重要的角色。

The market continues to be dominated by adult patient applications. Hospitals remain the primary users, while ambulatory surgical centers are growing rapidly with the shift toward outpatient care.

技术创新：便携化、数字化与可持续性

制造商优先开发更易用、更便携、更适合去中心化医疗环境的设备。紧凑型一次性鼻咽喉镜改善了耳鼻喉科的工作流程，数字化集成系统支持更快的诊断。同时，业界对可持续性的关注也在增加——如何在保持一次性设备卫生优势的同时减少环境影响，正在成为一个重要的创新方向。

Manufacturers are prioritizing devices that are easier to use, more portable, and better suited for decentralized care environments. Recent developments include compact single-use rhinolaryngoscopes and digitally integrated systems, along with increasing attention on sustainability.

市场的关键增长驱动包括：诊断中心和门诊设施的扩张、内窥镜在ICU和重症监护中的使用增加、政府感染防控计划的推进。但存在一些制约因素，如医生诊所的采用率有限、从可重复使用系统转换涉及的成本和运营调整。

Growth is being supported by expansion of diagnostic centers and outpatient care facilities, increased use of endoscopic procedures in ICU settings, and government initiatives focused on infection prevention.

竞争格局与增长机遇

市场相对集中，Ambu A/S、波士顿科学、卡尔史托斯、奥林巴斯和富士胶片等领先企业主导创新方向。这些公司正在扩大生产能力、推出新产品、加强分销网络。机会集中在高需求品类和不断演变的医疗服务模式上——支气管镜将产生可观的增量收入，医院和成人患者群体持续强劲。

The market is relatively concentrated, with key players including Ambu A/S, Boston Scientific Corporation, Karl Storz SE & Co. KG, Olympus Corporation, and Fujifilm Holdings Corporation. Opportunities are centered around high-demand product categories.

美国因高手术量和持续的医疗技术投资，将保持最大的增长贡献。企业策略正聚焦于便携式、数字化集成设备、全球合作扩大覆盖面和供应链优化。可持续性举措在产品开发中的分量也在增长。

The United States is expected to remain a major growth contributor. Companies are increasingly investing in advanced product development, partnerships, and sustainability initiatives.

总结与展望

一次性内窥镜市场在感控意识、微创手术普及和医疗模式转变的共同推动下保持高速增长。随着设备变得更加智能、便携和环保，这个市场在提升诊断效率、降低感染风险和改善患者体验方面将发挥越来越重要的作用。

The disposable endoscopes market maintains high growth driven by infection control awareness, minimally invasive surgery adoption, and healthcare delivery transformation. As devices become smarter, more portable, and more sustainable, this market will play an increasingly important role in improving diagnostic efficiency and patient outcomes.

数据来源：The Business Research Company (TBRC) | www.thebusinessresearchcompany.com

关于The Business Research Company

The Business Research Company (TBRC)是一家领先的市场情报公司，在企业、市场与消费者研究领域享有盛誉。我们已发布超过17,500份报告，覆盖27个行业与60多个地区。我们的研究基于1,500,000个数据集、广泛的二手研究以及对行业领袖的独家访谈。

我们通过市场进入研究包、竞争对手追踪包、供应商与经销商包等专项服务，提供持续及定制化研究支持。

https://www.thebusinessresearchcompany.com